HARMON SMITH: Open Payments
NPI 1215028253 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 84 payments from 18 companies in 2025. Trend: 2023 $1,316 · 2024 $1,427 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $235 |
| Amgen Inc. | 15 | $218 |
| GlaxoSmithKline, LLC. | 10 | $170 |
| Novo Nordisk Inc | 10 | $168 |
| ABBVIE INC. | 9 | $136 |
| PFIZER INC. | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Lilly USA, LLC | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
Products named: OTEZLA, TRELEGY ELLIPTA, Kerendia, Wegovy, KRYSTEXXA, COBENFY, FARXIGA, BREZTRI.
Industry payments across GA — which companies pay providers there.
